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Obesity is a multifactorial disease related to metabolic disorders and associated with
genetic determinants. Currently, ion channels activity has been linked to many of
these disorders, in addition to the central regulation of food intake, energetic balance,
hormone release and response, as well as the adipocyte cell proliferation. Therefore,
the objective of this work is to review the current knowledge about the influence of ion
channels in obesity development. This review used different sources of literature (Google
Scholar, PubMed, Scopus, and Web of Science) to assess the role of ion channels in
the pathophysiology of obesity. Ion channels present diverse key functions, such as
the maintenance of physiological homeostasis and cell proliferation. Cell biology and
pharmacological experimental evidences demonstrate that proliferating cells exhibit ion
channel expression, conductance, and electrical properties different from the resting
cells. Thereby, a large variety of ion channels has been identified in the pathogenesis
of obesity such as potassium, sodium, calcium and chloride channels, nicotinic
acetylcholine receptor and transient receptor potential channels. The fundamental
involvement of these channels on the generation of obesity leads to the progress in
the knowledge about the mechanisms responsible for the obesity pathophysiology,
consequently emerging as new targets for pharmacological modulation.
Keywords: energetic metabolism, food intake, adipose cells, ion channels, obesity
INTRODUCTION
Obesity is an important disease associated to the excessive accumulation of body fat, leading to
weight gain and the development of chronic disorders, including arterial hypertension, type 2
diabetes mellitus, dyslipidemias, sleep apnea, and cancer (Jeffreys et al., 2003; Van Gaal et al., 2006;
Pischon et al., 2008; Whitlock et al., 2009; Vucenik and Stains, 2012; Singh et al., 2013). Currently,
it affects 35% of adults aged 20+ with a rising prevalence (World Health Organization [WHO],
2014).
Multiple factors are involved in the origin of this disease, involving genetic determinants, as
well as environmental, psychosocial and psychobiological factors (Comuzzie and Allison, 1998;
Bocchieri et al., 2002; Noll et al., 2007). Meanwhile, regardless of its cause, the body weight results
from a complex interaction between physio- and psychological components that control food
intake and energy expenditure (Martinez, 2000).
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Food intake is regulated centrally and it is influenced
by the phenomena of hunger, satiety and appetite. Neurons
located in several regions of the hypothalamus (ventromedial,
lateral hypothalamic, arcuate and paraventricular nuclei) and
in extra hypothalamic regions, including hindbrain (nucleus
tractus solitarii), midbrain (ventral tegmental area) and
forebrain (nucleus accumbens), are associated with the energetic
homeostasis in human (Thaler et al., 2013).
Specifically, the arcuate nucleus (ARC) in the mediobasal
hypothalamus contains different types of neurons correlated to
the expression of orexigenic peptides, such as neuropeptide Y
(NPY) and agouti-related peptide (AgRP), which stimulate food
intake and reduce the body energy expenditure. In contrast,
neurons expressing anorexigenic peptides derived from pro-
opiomelanocortin (POMC), cocaine and amphetamine regulated
transcript (CART) trigger opposite effects, such as decreased food
intake and increased body energy expenditure (Bing et al., 1996;
Schwartz et al., 2000; Broberger, 2005; Huda et al., 2006). In
addition, the nucleus tractus solitarii (nTS) receives gustatory and
visceroceptive signals, especially from vagal afferents synapse,
and sends projections to different brain regions in order to
regulate the food intake (Harding and Leek, 1973; Appleyard
et al., 2005). Recently, several studies have suggest a role
of ion channels in the regulation of synaptic function in
the brain associated to the increase/decrease of expression of
orexigen/anorexigen peptides and the energetic homeostasis
(Olds and Xu, 2014).
The energetic balance has also multiple periphery influences,
mainly the blood glucose levels, neurotransmitters, adipokines
and cytokines, such as the hormones involved in glucose
metabolism (adiponectin and resistin), inflammation [tumor
necrosis factor-α (TNF-α) and interleukin 6 (IL6)], coagulation
[plasminogen activator inhibitor type-l (PAI-1)], blood pressure
(angiotensinogen and angiotensin II) and feeding behavior
(leptin and ghrelin), which are responsible for the obesity
progression (Chu et al., 2001; Yamauchi et al., 2001; Vendrell
et al., 2004; Ran et al., 2006; Ohashi et al., 2014). Therefore,
peripherally released hormones can regulate the development of
obesity throughout the modulation of central events.
Leptin is a key adipokine in the regulation of energy
intake/expenditure that shows concentrations proportional to
body fat mass (Sinha and Caro, 1998). Leptin acts on the
ARC stimulating the anorexigenic neurons and inhibiting the
orexigenic ones (Druce and Bloom, 2006). Another important
event promoted by this adipokine is the induction of post-
translational processing of the precursor molecule of POMC,
leading to the production of melanocortin peptides that present
anorexigenic property (Broberger, 2005). Mutations affecting the
leptin-melanocortin pathway involving genes encoding leptin
and/or its receptor and the prohormone convertase enzyme
that processes the POMC constitute the more present genetic
alterations in obese (Farooqi and O’Rahilly, 2008). Ghrelin
is produced in the stomach (Tschop et al., 2000; Wiedmer
et al., 2007) and is the only peripheral hormone that stimulates
the expression of orexigenic neuropeptides. Thus, it is known
to induce increase in hunger and food intake (Huda et al.,
2006). Before meals, the levels of ghrelin are raised, and after
the ingestion of nutrients, its levels are suppressed (Tschop
et al., 2001). Additionally, adiponectin is a hormone which is
synthesized, exclusively, by adipocytes and acts inhibiting the
hepatic glucose production, while increasing glucose uptake in
muscle, as well as the oxidation of fatty acids in the liver
and muscles, causing energy expenditure (Scherer et al., 1995;
Kadowaki and Yamauchi, 2005). Therefore, obese individuals
present low levels of adiponectin (Lindsay et al., 2002; Hajer et al.,
2007).
The adipose tissue has the ability to store excess calories
resulting in the process of hypertrophy and/or hyperplasia
(Ferranti and Mozaffarian, 2008). The deposition and release
of fatty acids from adipose tissue (as triglyceride) alters the
food intake and energy expenditure. Moreover, different studies
showed that adipose tissue is generally composed by 50% of
adipocytes and the remaining 50% are cells such as preadipocytes,
vascular cells, neural, leukocytes and cells of the immune system
(Gustafson, 2010; Maenhaut and Van de Voorde, 2011). Based
on functional and morphological differences, this tissue was
divided into two main types, white adipose tissue (WAT) and
brown adipose tissue (BAT). The WAT acts as an energy storage
and is an active endocrine organ, releasing the free fatty acids
and adipokines. Conversely, the BAT presents cells which are
characterized by multilocular lipid droplets and an increased
number of mitochondria, which express uncoupling protein 1
(UCP1), which uncouples the rates of substrate oxidation and
ATP production by favoring a loss of protons and thus energy
release. Thus, BAT is associated with thermogenesis (Tam et al.,
2012).
Regarding the diagnosis of obesity, anthropometric criteria
are the most often used, such as body mass index (BMI),
measurement of waist circumference, waist-hip ratio, and
skinfold test with the use of tweezers to evaluate the percentage
of fat (Racette et al., 2003; McArdle et al., 2008). Additionally,
there are other techniques for the assessment of body weight,
including electrical bioimpedance (BIA), hydrostatic weighing
and dual-energy X-ray absorptiometry (DEXA): BIA evaluates
the resistance to a low frequency electrical current, considering
that the current travels through the aqueous compartments
and not through the greasy ones, where the flow impediment
occurs (Kushner and Schoeller, 1986). The hydrostatic weighing
determines the total volume of the body by analyzing the
difference between the weight of an object in water and air,
determining the density of the whole body (Schoeller et al.,
1980). In DEXA analysis, the composition of soft body tissues is
measured, by using the ratio of absorption of X-rays of different
energies attached to adipose tissue mass (Kohrt, 1998).
Obesity treatment is based on multiple approaches that
may encourage behavior change in long term, through energy-
reduced diets, physical activity and/or exercise, pharmacotherapy
and surgery (National Institutes of Health [NIH], 1991, 2000;
Rosenbaum et al., 1997; Klein, 1999; Bray and Tartaglia, 2000).
There is a consensus among the National Institutes of Health,
the National Heart, Lung and Blood Institute and the North
American Association for the Study of Obesity that the choice
of treatment depends on the degree of obesity and the presence
of comorbidities. Accordingly, for BMI ≥ 25 kg/m2, changes in
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lifestyle are recommended (physical activity, diet, and behavior),
for BMI into 27.7–29.9 kg/m2, in the presence of comorbidities
or for BMI ≥ 30 kg/m2, in the absence of comorbidities,
the use of pharmacotherapy is recommended. The surgery
for weight reduction is recommended for patients with severe
obesity (BMI > 35 kg/m2) in the presence of comorbidities,
or individuals with a BMI > 40 kg/m2 in the absence of
comorbidities (National Institutes of Health [NIH], 2000).
Nowadays, the treatment of obesity remains a challenge. Most
anti-obesity drugs currently prescribed target appetite regulation
or decreasing in the absorption of nutrients (Bays, 2004). Most of
them have significant side effects, and do not act specifically on
regulatory functions of appetite in the hypothalamus, but exhibit
a broad spectrum of actions. In many cases, beneficial effects
remain limited (Heymsfield et al., 1999).
The most prescribed drugs for the treatment of obesity are
sibutramine (serotonin and norepinephrine reuptake inhibitor)
and orlistat (gastrointestinal lipase inhibitor), both prescribed
for long-term use (Cannon and Kumar, 2009). The use of
sibutramine for weight reduction has favorable effects on
risk factors for cardiovascular disease (increasing high-density
lipoprotein and decreasing levels of cholesterol and triglycerides
in the blood; Dujovne et al., 2001). However, the use of
this drug is contraindicated in patients with uncontrolled
hypertension, coronary artery disease, cardiac arrhythmias,
congestive heart failure or stroke, because it can increase blood
pressure and heart rate (Kim et al., 2003). It is recommended
the use of orlistat associated with multivitamin supplements,
considering that orlistat affects the absorption of fat-soluble
vitamins (A, D, E, and K) that are essential for the body
(Cannon and Kumar, 2009). In obese patients, the benefits
of this drug use is associated with lower incidence of type 2
diabetes, reduction of total cholesterol, LDL cholesterol and
triglyceride levels as well as the levels of glycated hemoglobin
(HbAlc) in diabetic (Aronne et al., 2009). Amfepramone
(diethylcathinone) and fenproporex are also inhibitors of
appetite, which act on the hypothalamic neurons, increasing
the release of norepinephrine and stimulating the noradrenergic
receptors, then, inhibiting hunger (Zaragoza et al., 2005;
Cohen, 2009). Other medications have been evaluated in obese
individuals, however, without formal indication for obesity
treatment.
Because of ethical limitations on studying the susceptibility
of human obesity, animal models of obesity has been proposed
to investigate the pathophysiological changes caused by this
disease (Pereira et al., 2003). Obesity has been induced in animals
by nerve injury, endocrine disorders, genetic, and/or dietary
modifications (Sclafani and Springer, 1976), which facilitates the
study of the pathophysiology of obesity and allows advances in
the development of new therapies.
Therefore, in view of the influence of obesity in the
development of chronic diseases affecting the life expectation
and the limitations of the current available treatment, this
revision focused on the involvement of ion channels in the
pathophysiology of obesity, as well as the role of these targets
as new approaches toward the development of new anti-obesity
drugs.
ION CHANNELS IN THE DEVELOPMENT
OF OBESITY
Ion channels play fundamental roles in diverse key functions,
such as maintenance of physiological homeostasis, cell
proliferation and signal transduction in a variety of cell types
and different cell stages (Nilius and Droogmans, 2001; Chen
et al., 2007). Cell biology and pharmacological experimental
evidences demonstrate that proliferating cells exhibit ion channel
expression, conductance, and electrical properties which are very
different from the resting cells (Conti, 2007). In this context,
the investigation of ion channels has been emerging as a new
approach in the study of the pathogenesis of obesity.
Ion Channels on Adipose Cell
Proliferation
Obesity development results from the expansion of WAT and
this process depends of stem cell proliferation (Gray and
Vidal-Puig, 2007). This process is dependent of ion channels
functionality (Chen et al., 2007). It is well-known that K+
channels are involved in cell proliferation, as the EGF-mediated
mitogenic signal transduction process, required for voltage-
gated K+ channels participating in G1/S-phase transition of
the cell cycle (MacFarlane and Sontheimer, 2000). Previous
studies reported the presence of voltage-gated K+ currents
(KV) in BAT isolated from the interscapular fat pads of
neonatal rats (Lucero and Pappone, 1989; Russ et al., 1993),
WAT differentiated from rats (Ramirez-Ponce et al., 1996)
and/or human preadipocytes (Ramirez-Ponce et al., 2003).
Additionally, Bai et al. (2007) identified three types of K+
currents on human adipose tissue-derived stem cells (hASCs):
a delayed rectifier-like K+ current (IKDR), a Ca2+-activated K+
current (IKCa) and a transient outward K+ current (Ito). In
addition, the mRNA of KV1.1, KV1.5, KV2.1, KV7.1, KV10.1,
and KV11.1 has been shown to correspond to IKDR; mRNA
of MaxiK (BKCa), KCNN3 (SKCa3) and KCNN4 (SKCa4),
corresponding to IKCa, and high mRNA levels of KV1.4,
KV4.2, and KV4.3, contributing to Ito. However, despite the
expression of these different K+ channels in hASCs, only
the IKDR current has been associated to its proliferation
(Table 1).
Hu et al. (2009) showed the crucial participation of
K+ channels in obesity. The knockdown or blockade with
4-aminopyridine and paxilline of KCa1.1 and KV4.2 channels,
respectively, related to Ito, increased the cell number of human
preadipocytes on G0/G1 phase, preventing cell cycle progression.
Thus, these data indicate the importance of K+ channels activity
to preadipocytes proliferation and differentiation, resulting in
obesity installing. Additionally, in brown adipocytes culture
obtained from rat, it has been demonstrated that the blockade of
KV channels with tetraethylammonium inhibits cell proliferation
(Pappone and Ortiz-Miranda, 1993). The brown adipocytes
are connected to metabolic energy expenditure and, therefore,
are important to prevent fat accumulation. Thus, a balance
in the activity of white and brown fat cells can be seen,
regulated by K+ channels, that prevent fat deposition. It
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TABLE 1 | Characterization of K+ channels associated to obesity.
Localization Species K+ channel
subtype (gene)
Comments Reference
Subcutaneous
preadipocytes
Human KV1.1 (KCNA1)
KV1.5 (KCNA5)
KV2.1 (KCNB1)
KV7.1 (KCNQ1)
KV10.1 (KCNH1)
KV11.1 (KCNH2)
KCa1.1 (KCNMA1)
KV4.2 (KCND2)
Promote preadipocytes proliferation Bai et al., 2007; Hu et al., 2009
Brown
adipocytes
Rat KV (?) Associated with adipose cells proliferation Pappone and Ortiz-Miranda, 1993
Central nervous
system
Mice Kir6.2 (Kcnj11) Mediates the glucose-sensitive neuronal excitation and
regulates food intake
Miki et al., 2001; Sohn, 2013
K2P/KV3 [Kcnk1–7,
9, 10, 12, 13,
15–17; Kcck18 (?)]
Activated by high glucose levels and inhibits
orexin/hypocretin release
Burdakov et al., 2006
KV1.3 (KCNA3) Regulation of energy homeostasis, body weight, and
insulin resistance
Xu et al., 2003, 2004
Rat KV3.1 (Kcnc1) Regulates response of taste cells to fat ingestion and
the leaning to high fat intake
Gilbertson et al., 2005
is still not clear the role of K+ channels in the genesis
of obesity. The data presented here ponder a similar role
of these channels on the proliferation of both white and
brown preadipocytes. It becomes important, therefore, to
determine which of these subtypes are predominant for the
evolution of the cell cycle in those two cell types and how
its dysfunction would lead to the development of obesity
(Table 1).
Other ion channels have been associated with proliferation
of preadipocytes. On 3T3-L1-preadipocytes, an establish a
model for adipocyte differentiation, and visceral adipose
tissue from both mice and human, Zhang et al. (2007) have
detected the expression of TRPV1 and have shown that
TRPV1 are important in preventing the proliferation and
differentiation of preadipocytes. Accordingly, the treatment
with capsaicin, a TRPV1 agonist, prevented the differentiation
of these cells. Likewise, it has been evidenced the TRPV1
downregulation during adipogenesis of preadipocytes as well
as on visceral adipose tissue from db/db and ob/ob mice,
suggesting that TRPV1 function prevents adipogenesis
and consequently obesity (Miller et al., 1996; Neal and
Clipstone, 2002) (Table 2). Additionally, Hu et al. (2010)
have detected Cl− currents on human abdominal subcutaneous
adipose tissue. Furthermore, it was verified the expression of
chloride channel-3 (CIC-3) on this tissue and its blockade
with tamoxifen reduced cell proliferation, suggesting the
role of Cl− channel in regulation of human preadipocyte
proliferation.
Therefore, all these data directs to a probable requirement
for hyperpolarized state of preadipocytes, which can be achieved
by the eﬄux of K+, inhibition of cation influx or even by
Cl− influx, to the progress of these cells in the cell cycle until
reaching the needed maturity state for their proliferation and
differentiation. Accordingly, drugs that prevent this progression
by acting on ion channels involved could provide new tools for
obesity therapy.
Ion Channels on Central Food Intake
Control
Some K+ channels have been shown to have an important role
in the central regulation of food intake, energy expenditure,
and glucose metabolism. The Kir6.2, suggested being the
KATP pore-forming subunit (Karschin et al., 1998; Zawar
et al., 1999; Miki et al., 2001), is expressed in neurons
of ventromedial hypothalamic nucleus (VMH), POMC and
melanin-concentrating hormone (MCH) neurons of lateral
hypothalamic area (LHA) of mice and mediates neuronal
glucose-excitation, acting as a glucose sensor during feeding.
The defective Kir6.2 prevents ATP-mediated KATP blocking,
leading to impaired glucose responsiveness by POMC neurons,
resulting in glucose intolerance (Sohn, 2013). Additionally,
this event has been observed in obese mice on a high-
fat diet, resulting in loss of glucose sensitivity by these
neurons, contributing to food intake overstimulation and obesity
progress (Miki et al., 2001). These data corroborate Rowe
et al. (1996), who showed that obese rats exhibit abnormal
electrophysiological responses in hypothalamic glucose-sensors
neurons to changes on extracellular glucose concentration,
whereas lean rats respond normally. The role of KATP on
regulating food intake behavior has been also shown to be
important in preventing age-dependent obesity. It was shown
that rapamycin-sensitive (mTOR) signaling is elevated in POMC
neurons of old mice, causing silencing of these neurons and
inhibition of leptin-induced release of the anorexigenic α-MSH,
associated with upregulation of KATP channel activity and an
aging-dependent high expression of Kir6.2 (Yang et al., 2012)
(Table 1).
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TABLE 2 | Characterization of TRPs associated to obesity.
Localization Species TRP channel
(gene)
Comments Reference
Adipocytes Mice TRPC1 (Trpc1)
TRPC5 (Trpc5)
Channels related to the adiponectin production Sukumar et al., 2012
TRPM8 (Trpm8) Menthol, a TRPM8 agonist, increases the expression of
UCP1 and the level of p-PKA
Ma et al., 2012
3T3-LI-
preadipocytes
Mice TRPV1 (Trpv1) Adipogenesis process is decreased Zhang et al., 2007
BAT Mice TRPM8 (Trpm8) Stimulation of this channel mediates BAT
thermogenesis
Ma et al., 2012
TRPA1 (Trpa1) Cinnamaldehyde, a TRPA1 agonist, increases the
UCP1 protein levels
Tamura et al., 2012
WAT Mice TRPV4 (Trpv4) Regulator of oxidative metabolism, thermogenesis, and
pro-inflammation gene
Ye et al., 2012
TRPM2 (Trpm2) Regulates of lipid metabolism Zhang et al., 2012
Perivascular
adipose tissue
Human TRPC1 (TRPC1)
TRPC5 (TRPC5)
Channels are related to the adiponectin production Sukumar et al., 2012
Visceral and
subcutaneous
adipose tissues
Human TRPV1 (TRPV1) Adipogenesis process is decreased Zhang et al., 2007
Mice TRPA1 (Trpa1) Cinnamaldehyde, a TRPA1 agonist, reduces the visceral
fat in both mice fed with a high-fat and high-sucrose
Tamura et al., 2012
TRCs Mice TRPM5 (Trpm5) Disruption on the channel abolishes the sweet, umami,
and bitter tastes
Zhang et al., 2003
EC cells Rat TRPA1 (Trpa1) Allyl isothiocyanate and cinnamaldehyde, TRPA1
agonists, increase [Ca2+]i, 5-HT release and delay
gastric emptying
Doihara et al., 2009; Nozawa et al., 2009
Whole body fat Human TRPV1 (TRPV1) SNP Val585IIe is associated to weight loss Hayes et al., 2000
Mice TRPM5 (Trpm5) TRPM5(−/−) mice present a loss on sucrose
preference and gain less weight that WT mice
Glendinning et al., 2012
TRPV1 (Trpv1) TRPV1(−/−) mice present equivalent energy intake that
WT mice
Motter and Ahern, 2008
Leptin and insulin are well-recognized as anorexigenic
hormones released from adipocytes and pancreatic beta cells,
respectively (Williams et al., 2011b). Typically, leptin activates
POMC neurons and leptin receptor (LepR)-expressing neurons
of ventral premammilary nucleus (PMV), known to release of
anorexigenic hormones (Cowley et al., 2001; Al-Qassab et al.,
2009; Williams et al., 2010, 2011a). However, their effects on
ion channels in the CNS are yet controversial. In the VMH,
insulin receptors expressed by the SF-1 neurons activate KATP
channels and suppress steroidogenic factor 1 (SF1) neuron
activity, which resulted in diet-induced obesity (Klockener
et al., 2011). In addition, insulin activates some arcuate
NPY/AgRP neurons, which release orexigenic hormones, leading
to hyperphagia state (Al-Qassab et al., 2009). Melanocortin is
another hormone important in regulating body fat accumulation.
Mutations on MC4R has been shown to induce obesity in
rodents and humans (Huszar et al., 1997; Vaisse et al.,
1998; Tallam et al., 2005), and its activation hyperpolarizes
parasympathetic preganglionic neurons in brainstem via PKA-
dependent activation of tolbutamide-sensitive KATP channels and
depolarize the sympathetic ones, which could be one of the
factors responsible to inducing obesity-associated hypertension.
However, this data is more associated with an obesity
consequence than a cause. The ion channels involved in
melanocortin pathways to regulate food intake and obesity
development have not yet been determined. Therefore, the effects
of these hormones on ion channels activity in neurons that
regulate food intake deserve an interesting focus for future
insights attempting to better understand their relationship with
obesity. Meanwhile, KATP channels appear to be promising
targets to treatment of obesity, focusing in drugs acting in CNS
neurons regulating food intake (Table 1).
KV1.3 has been implicated in the regulation of energy
homeostasis, body weight and insulin resistance (Xu et al., 2003,
2004). This channel was shown to act as a metabolic sensor
responding to insulin levels in mitral cells of olfactory bulb,
and its removal increases the weight gain (Marks and Fadool,
2007; Biju et al., 2008). Mitral cells of the olfactory bulb function
as internal chemical sensors of metabolic state by modulating
KV channels predominantly expressed in these neurons (Fadool
et al., 2000). KV1.3 knockout mice fed a high-fat diet exhibit
increased light-phase metabolism in addition to reduced weight
gain, reduced levels of sugar, leptin and insulin in the blood, and
increased energy expenditure (Xu et al., 2003, 2004; Li et al., 2006;
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Tucker et al., 2008; Fadool et al., 2011; Tucker K. et al., 2012;
Tucker K.R. et al., 2012). Additionally, these knockout exhibited
metabolic alterations including increase in energy expenditure
and locomotor activity, resistance to diet- and genetic-induced
obesity and increased insulin sensitivity (Fadool et al., 2004; Xu
et al., 2004; Tucker et al., 2008). Therefore, linking to the role of
KATP channels in hypothalamic areas to regulate food instinct,
the KV1.3 channels seem to have an important role at the CNS
too. These channels appear to be important in regulating food
drive through the olfactory effects which are responsible for
stimulating food intake (Table 1).
Nicotinic receptors have been shown to have an important
role to prevent fat accumulation and to induce fat degradation.
In a model of type 2 diabetes, the homozygous leptin-resistant
db/db obese mouse, Marrero et al. (2010) measured the effects
of a novel α7 nAChR-selective agonist, TC-7020, and showed
reduction of food intake and weight gain. These parameters were
reversed by using a janus kinase 2 (JAK2) specific inhibitor (AG-
290), demonstrating that the α7 nAChRs plays an important
role in the body weight control and it involves JAK2 signal
transducer and activator of transcription 3 (STAT3) signaling
pathways. Similarly, C57BL/6J mice with a high-fat diet treated
with galantamine, an acetylcholinesterase (AChE) inhibitor that
enhances cholinergic signaling and also acts as a positive
allosteric modulator of a7 nAChR, presented reduction on food
intake, body weight and abdominal adiposity as well as an
improvement on blood glucose, insulin resistance, and hepatic
steatosis (Satapathy et al., 2011) (Table 3).
Cigarette smoking habits have been associated with less
body fat distribution, body weight, insulin resistance and
obesity (Chiolero et al., 2008; Clair et al., 2011). Indeed,
the smoking cessation increases body weight (Perkins, 1993).
Experimentally, nicotine administration to rodents and humans
suppresses appetite, increases energy expenditure and alters
feeding behavior (Jo et al., 2002; Fornari et al., 2007; Zoli
and Picciotto, 2012). The mechanisms involved in nicotine-
induced decrease in body weight have been correlated to
both central and peripheral nicotinic cholinergic signaling. In
CNS, nAChRs composed by both α7 and α/β subunits were
detected throughout areas of the hypothalamus that regulate
appetite, food consumption and body mass. In previous studies,
it was revealed from moderate to high levels of α4, α7,
and β2-mRNAs in hypothalamus, with particularly prominent
expression in the supraoptic or suprachiasmatic nuclei and
lateral hypothalamus (Jo and Role, 2002). Moreover, although
the α3β4 nAChR is the predominant nicotinic receptor in
the peripheral nervous system, it is less widely distributed
in the rat brain (Dwyer et al., 2008) and has been related
to nicotine effects on mice hypothalamus to decrease food
intake. In particular, the activation of α3β4 nAChRs in POMC
cells in the ARC decreases food intake and increases energy
expenditure (Williams and Schwartz, 2005; Mineur et al., 2011)
(Table 3).
The gamma-aminobutyric acid type A receptor (GABAA) has
been associated to the body weight regulation. Tong et al. (2008)
showed that inhibition of GABA release from AgRP neurons of
mice prevents obesity. Additionally, Vong et al. (2011) showed
a lean phenotype in the presence of defective synaptic release
of GABA from NPY/AgRP neurons. This effect was associated
to a decrease on inhibitory post-synaptic currents (IPSCs) in
anorexigenic POMC neurons. Beyond this, Wu et al. (2009) have
showed that inhibition of GABAA receptor with the antagonist
TABLE 3 | Characterization of nAChRs associated to obesity.
Localization Species nAChRs (gene) Comments Reference
Central nervous
system
Human α7 (CHRNA7)
α/β (CHRNA1, 2, 3,
4, 5, 6, 9, 10 and
CHRNB1, 2, 3, 4)
Associated to the energetic metabolism regulation Jo et al., 2002
Rat α3 (Chrna3)
β4 (Chrnb4)
Distributed in both the peripheral and central nervous
system. Associated to food intake regulation
Dwyer et al., 2008
Mice α4,7 (Chrna4, 7)
β2 (Chrnb2)
Express in hypothalamus regulating appetite, food
consumption, and body mass
Jo and Role, 2002
α3 (Chrna3)
β4 (Chrnb4)
Regulates food intake Mineur et al., 2011
Adipose tissue Human α7 (CHRNA7) Gene expression is reduced in obese individuals Cancello et al., 2012
α2 (CHRNA2) Gene expression is associated to overweight/obesity Kim, 2008
α3–5 (CHRNA3,4,5) Associated to alteration on BMI Freathy et al., 2011; Zhu et al., 2013
α3, 5 (CHRNA3,5)
β3, 4 (CHRNB3,4)
Associated to abdominal obesity Zhu et al., 2014
Rat α1–7, 9, 10 (Chrna
1, 2, 3, 4, 5, 6, 7, 9,
10) β1–4 (Chrnb1,
2, 3,4)
δ (Chrnd)
ε (Chrne)
Promote nicotine-induced adipocytes adiponectin and
FFA release
Liu et al., 2004
Mice α2 (Chrna2) β1–2
(Chrnb1,2)
Alterations in lean body mass and fat storage Somm et al., 2014
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bicuculline, in the parabrachial nucleus (PBN), a region that
regulates taste reactivity (Higgs and Cooper, 1996), decreases the
feeding and increases the loss of body weight. Thus, there are
evidences linking the inhibitory effect of GABAA receptors in
anorexigenic hypothalamic neurons that may be responsible for
promoting obesity development.
Monosodium glutamate has been shown to cause
hypothalamic damages (Kaufhold et al., 2002) and the
chronic overconsumption of the aminoacid glutamate (GLU)
promotes obesity (Hermanussen and Tresguerres, 2003). In
this view, the selective GLU-gated calcium channels antagonist,
memantine, has been reported to display neuroprotective effects.
Additionally, obese young women since childhood or after the
first pregnancy treated with memantine presented protection on
physiological regulation of appetite affected by high nutritional
GLU, as well as being led to marked body weight reduction
within a few days (Hermanussen and Tresguerres, 2005).
Probably activation of Ca2+ channels in the hypothalamus,
such as that produced by glutamate on its ionotropic NMDA-
R, promotes release of orexigenic hormones, affecting the
nutritional status and triggering obesity. However, more works
in this field should be conducted to better characterize the role of
these ion channels.
Ion Channels on Sleep-Vigilant Cycle
Dysfunction-induced Obesity
There are few studies linking sleep and metabolism, being this
interplay only currently receiving attention. In a study made by
Uebele et al. (2009) using mice with deletion of CaV3.1 channels
(Cacna1g KO mice), a model that promotes fragmented sleep,
the potential link between sleep and obesity was investigated.
The authors found that KO mice presented less weight gain and
amount of fat after inducing them to a high-fat diet (HFD),
compared to the wild type mice (WT). Moreover, it was showed
that the resistance on weight gain observed to KO mice was due to
metabolic rate changes in these animals, in a manner that did not
affect core body temperature. Furthermore, the authors assessed
a possible similar effect using a T-type Ca2+ channel antagonist
(TTA-A2) and, initially, they observed that the inhibition of
T-type Ca2+ of WT mice caused sedation and decreased on
active wake, consistent with altering thalamocortical neuronal
activity. Additionally, these WT mice presented less weight
gain after inhibition of T-type Ca2+ and, interestingly, this
difference was observed only when the mice received HFD.
All the results were similar to that observed on Cacna1g KO
mice. Additionally, animals fed with HFD presented reduced
food intake, not on the active phase, but in the inactive phase.
These effects probably result from a better alignment of diurnal
feeding patterns with daily changes in circadian physiology and,
potentially, an increased metabolic rate during the active phase.
Thus, these data suggest a role for CaV3.1 in co-regulating sleep
and weight maintenance and data from pharmacological studies
demonstrate that potent and selective T-type calcium channel
antagonists reduce– wakefulness, diet-induced weight gain, and
improve- body composition, suggesting this ion channel class
may provide a novel therapeutic target for the treatment of
obesity.
Additionally, it has been shown that elevated glucose levels,
reached, e.g., after meal, activate a two-pore domain K+
channel (K2P) and inhibits orexin/hypocretin release by LHA
neurons, regulating the sleep-vigilant cycle (Burdakov et al.,
2006). Thus, impaired K2P function can emerge as a reason
of hyperphagia promoted by release of high amounts of
this hormone associated with sleep-vigilant cycle dysfunction
(Table 1).
Therefore, there must be an interplay between Ca2+ and K+
channels that regulates sleep-vigilant cycle and food intake as
well, emerging as interesting targets in the CNS to treat obesity,
especially the sleeplessness.
Ion Channels on Peripheral Food Intake
Control
Free fatty acids are able to activate peripherally taste receptor
cells (TRCs; Fukuwatari et al., 2003), the stimulus involves an
interaction between the tastant and ion channels or receptors
localized in most cases on the apical membranes of the TRCs.
The initial events in the taste transduction of free fatty acids
include an inhibition of delayed rectifying potassium channels
(DRK) associated with KV3.1 channels (Gilbertson et al., 1997,
1998, 2005). Gilbertson et al. (2005) have demonstrated that DRK
currents are inhibited in obese-resistant rats (O-R), but not in
obesity-prone (O-B) test cells, in response to polyunsaturated
fat acids (PUFAs), and this effect was associated with the
greater activation of taste cells in O-R than that in O-B.
Additionally, TRCs in O-R would be activated to a greater
degree by PUFAs than those from O-B. Likewise, the DRK
channels were not found in O-R, indicating that PUFAs do not
inhibit K+ currents by these channels in O-B, and they are
the most responsible for the taste cells inhibition in obese rats,
which might explain the preference of these obese rats to a
high fat dietary, while the resistant-rats tend to eat much less
(Table 1).
TRPM5 is another ion channel abundantly identified in
TRCs which participates in sweet, umami, and bitter perception.
The disruption of this channel gene in mice abolishes the
transduction of these tastes (Pérez et al., 2002; Zhang et al.,
2003). TRPM5(−/−) mice were shown to present the same
pattern of food intake and gained less weight than wide-type
mice when fed a high-sugar diet, being this effect probably
due to the loss of sucrose preference (Glendinning et al.,
2012). Interestingly, these data corroborate Gilbertson et al.
(2005), as showed previously, that demonstrated that inhibited
state of taste cells leads to obesity sensitivity. Additionally,
TRPM5(−/−) mice also abolished the preference for fat and
reduced the fatty acid-induced [Ca2+]c increase, suggesting
that TRPM5 also plays a key role in lipid taste perception
(Oike et al., 2006; Sclafani et al., 2007; Liu et al., 2011)
(Table 2).
Ion Channels on Body Energetic
Expenditure
Some ion channels have been associated with the regulation
of energetic expenditure. The nicotinic cholinergic signaling, in
Frontiers in Pharmacology | www.frontiersin.org 7 March 2016 | Volume 7 | Article 58
fphar-07-00058 March 24, 2016 Time: 15:38 # 8
Vasconcelos et al. Ion Channels in Obesity
special, in metabolic tissue, is one of them. Liu et al. (2004)
have shown that α1–7, 9–10, β1–4, δ and ε subunit mRNAs
are expressed in rat adipocytes, and the release of FFA by this
cell has been known to increase nicotine concentration. Recent
studies of Somm et al. (2014) have shown that in mouse WAT,
α2 and β1 were the most expressed nAChR subunits. Meantime,
mouse BAT expresses α2 and comparable amounts of β1 and β2
nAChR subunits. Then, although in a α7β2 nAChR(−/−) mice
model it was verified the unaltered body weight, a decreased
fat storage was observed. Additionally, Cancello et al. (2012)
have demonstrated the expression of α7 nAChR in isolated
mature adipocytes and human subcutaneous adipose tissue
(SAT). Meanwhile, the expression of this receptor was associated
with decreased SAT obtained from obese human compared to
normal-weight human. In addition, α7 nAChR had 75% lower
expression in mature adipocytes isolated from morbidly obese
human compared to adipocytes from normal-weight human.
These receptors modulates inflammatory gene expression in
human adipocytes and are linked to adipocyte lipid catabolism
(Table 3).
In human studies, polymorphisms in genes encoding nAChRs
have been focused to examine the potential involvement of
nicotinic receptors variants on the distribution of body fat. The
SNP in the nAChR α2 subunit gene (CHRNA2) was associated
with overweight/obesity (Kim, 2008). There was no association
between the BMI and the genotype of 15q25 SNP (CHRNA5-
CHRNA3-CHRNB4 gene region) in the never smokers, however,
in smoking individuals it was observed an association between
the 15q25 variant and BMI, highlighting the smoking habit as a
probable cause of reduced BMI and obesity resistance (Freathy
et al., 2011; Zhu et al., 2013) (Table 3).
Regarding TRP channels, genetic approaches of human
TRPV1 showed a SNP, Val585Ile, associated with weight loss.
It was showed that the presence of Val/Val and Val/IIe variants
leads to the loss of twice as much abdominal fat in response
to vanilloids, as those with IIe/IIe (Hayes et al., 2000; Snitker
et al., 2009). Indeed, the energy intake is decreased in humans
that consume red chili pepper (Yoshioka et al., 1999) and the
repeated intake of CH-19 Sweet, a non-pungent red pepper,
reduces the body weight and suppresses body fat accumulation
due to the sympathetic nervous activation, which leads to fat
acids mobilization (Kawabata et al., 2006). The balance of the
literature suggests that both capsaicin and capsiate augment
energy expenditure and enhance fat oxidation, especially at
high doses (Ludy et al., 2011). In addition, Ma et al. (2012)
showed a functional TRPM8 expression on BAT, associated with
metabolic energy expenditure and the use of menthol, a TRPM8
activator, increases the expression of UCP1, located in the inner
mitochondrial membrane, responsible for thermogenesis in BAT
(Vogler et al., 2008). TRPM2 has also been shown to be involved
in the energy expenditure as evidenced for Zhang et al. (2012),
but conversely, TRPM2(−/−) mice were resistant to obesity after
4–10 months of high-fat feeding. These animals presented greater
energy expenditure and elevated expression of lipid metabolic
genes in WAT. Additionally, white adipocytes from TRPV4(−/−)
mice fed a high-fat diet were smaller and exhibited enhancement
in the energy expenditure, due to the elevated levels of UCP1
expression. Thus, Ye et al. (2012) suggest that TRPV4 negatively
regulates oxidative metabolism. In addition, Kusudo et al. (2012)
have shown that inactivation of the TRPV4 gene induces an
increase in TRPC3 and TRPC6 expression and calcineurin
activity in mice. The energy metabolism was altered due to
the expression of genes involved in fuel oxidative in skeletal
muscle, contributing to the resistance to obesity. Likewise,
Tamura et al. (2012) have reported that the supplementation with
cinnamaldehyde, a TRPA1 agonist, increased the UCP1 protein
levels in the interscapular BAT and reduced the visceral fat in
mice fed with diet rich in fat or sucrose. Therefore, these data
support the key role of TRPs on regulating energy expenditure
involving specially the activity of BAT (Table 2).
It has also been extensively reported that intracellular Ca2+
([Ca2+]i) appears to be involved in metabolic derangements,
including obesity and insulin resistance. It was previously
reported that agouti-induced obese mice present high basal
[Ca2+]i as well as increased Ca2+ influx rate, also associated
with high expression and activity of fatty acid synthase (FAS)
and increased triglycerides accumulation in 3T3-L1 adipocytes
(Zemel et al., 1995). Interestingly, FAS activity has been prevented
by Ca2+ channel blockade with nitrendipine (Jones et al., 1996).
Moreover, it was reported that chronic hyperinsulinemia induces
an increase in FAS mRNA level and activity in both rat liver
and WAT (Chakrabarty and Leveille, 1969). In this context,
Kim et al. (1996) reported that treatment of obese mice with
nifedipine normalized both FAS mRNA and plasma insulin levels,
associated with a reduction of fat pad mass in agouti-induced
obese mice, together with an increase in the skeletal muscle
weigh increase, which can be associated with the use of energy
from adipose store by muscle cells. Indeed, it was also observed
that the treatment corrected the reduction in core temperature
of obese mice, which can be explained by the increase in
energy expenditure by skeletal muscle. This effect was associated
with a possible reduction on Ca2+ levels on pancreatic β-cells,
reducing the insulin secretion, or due to an improvement in
insulin sensitivity on these mice. Alternatively, it is not discarded
that Ca2+ can acts in transcriptional level to increase the FAS
expression. Therefore, nifedipine was able to reduce lipogenesis
and insulin resistance in obese mice. Early evidence has already
been reported, according to which the anti-obese effect of a Ca2+
channel blocker, benidipine, which reduced mice body weight
associated with the increase in blood flow to BAT, functions as
the main thermogenic organ (Yoshida et al., 1994).
Together, these data bring interesting information regarding
nicotinic, TRPs and calcium channels as key ion channels
responsible for regulating energy expenditure. Therefore, new
drugs targeting these channels could emerge as new approaches
in the field of obesity treatment.
Ion Channels on Accelerated Gastric
Emptying Leading to Overeating
The accelerated gastric emptying and thus reduced nutrient
absorption has been linked with food overconsumption and
obesity development. Nozawa et al. (2009) have showed
the expression of TRPA1 in the gastrointestinal tissues and
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enterochromaffin cells (ECs) in humans, mice and rats. The
stimulation of TRPA1 by allyl isothiocyanate (AITC) and
cinnamaldehyde increased 5-hydroxytryptamine (5-HT) release
from EC cells, which is known to accelerate the gastric emptying
in human and it is known to the overconsumption on a HFD and
subsequent obesity (Wright et al., 1983; Zahorska-Markiewicz
et al., 1986; Tosetti et al., 1996) (Table 2). Furthermore, there
are reports suggesting that gastric emptying of solid food is
accelerated in obese subjects, which precipitates hunger and
frequent eating (Wright et al., 1983; Tosetti et al., 1996). In
obese humans, accelerated gastric emptying may be one of
the contributing factors to overconsumption on a HFD and
subsequent obesity (Wright et al., 1983; Zahorska-Markiewicz
et al., 1986; Tosetti et al., 1996). In this context, Li et al. (2013)
reported Ca2+ and K+ currents in antral circular smooth muscle
cell. The diet-induced obese-prone rats exhibit accelerated gastric
emptying attributed to a higher density of L-type Ca2+ currents
(IBa,L) and inactivation or low density of K+ currents, being
them the responsible for the high Ca2+ currents amplitude
in these cells and thus increasing gastric emptying, leading to
overconsumption and obesity.
PERSPECTIVES
In view of the large amount of information regarding the
involvement of ion channels in the obesity development, as well
as the development of suitable animal models, a new unexplored
aspect arises to establish novel alternatives for obesity treatment
having as targets deregulated molecular aspects in the genesis of
this disease. Various ion channels have been identified in several
cell types as important regulators of some functions related to
the development of obesity. The K+ channels were the most
well-studied and have been associated with the proliferation of
adipose cells, central and peripheral regulation of food intake and
gastric emptying time, all preponderant for the development of
obesity. Other channels, such as TRPs and nicotinic receptors,
are involved in many of these functions. The Ca2+ channels,
although still not better explored, has been associated particularly
in unusual obesity factors, such as disruption of the sleep-wake
cycle, as well as chloride channels not yet explored, but identified
in some cell types involved in obesity. In this sense, further
research targeting important ion channels in the pathogenesis
of obesity are promising for the development of more effective
drugs to treat the disease. Accordingly, drugs that act on the ion
channels described, specially K+ channels, may be promising to
the further treatment of obesity.
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